Ozark Health Ventures, LLC dba Cancer Research for the Ozarks (CRO)

描述(由申请人提供)：26年来，欧扎克癌症研究(CRO)通过社区临床计划为密苏里州西南部和周边地区的农村社区提供了NCI批准的临床试验。CRO渴望过渡到NCI社区肿瘤学研究计划(NCORP)社区站点，并在密苏里州南部、中部和东部以及伊利诺伊州南部扩大访问范围。在过去的五年里，CRO增加了五个组成部分，扩大到密苏里州中部和东部以及伊利诺伊州南部的人口。通过包括现任首席调查员Jay Carlson在内的杰出首席调查员的高瞻远瞩的领导，DO将这一主要是农村人口的人口转移到NCI(NCORP)。从一开始，CRO就得到了两个国家公认的医疗保健系统的支持，这两个系统是密苏里州斯普林菲尔德的CoxHealth和Mercy Hospital Springfield，这为改变广泛的实践社区提供了一个独特的机会。CRO可以接触到非肿瘤医生和包括遗传学家在内的其他医疗专业人员的广泛网络，以及广泛的社区服务提供者网络。基于其经验和扩张，CRO有信心每年在癌症治疗、预防和控制方面获得200多项应计和信用。CRO热衷于重新调整研究试验的范围，包括扩大癌症预防和控制计划。CRO完全支持新的NCORP优先事项，以解决癌症护理提供问题，差异与正在进行的努力一致，以改善CRO所有组成部分的获取、服务提供和结果。

DESCRIPTION (provided by applicant): For over 26 years, Cancer Research for the Ozarks (CRO) has provided access to NCI-approved clinical trials to the rural communities of southwestern Missouri and surrounding areas through the Community Clinical Program. CRO is eager to transition to an NCI Community Oncology Research Program (NCORP) Community Site and expand access throughout south, central, and eastern Missouri as well as southern Illinois. During the past five years, CRO has added five components expanding to a population that spans central and eastern Missouri, and southern Illinois. Through the visionary leadership of its outstanding Principal Investigators including current Principal Investigator, Jay Carlson, DO, this largely rural population to NCI (NCORP). From its inception, CRO has had the support of the two nationally recognized health care systems, CoxHealth and Mercy Hospital Springfield in Springfield, Missouri providing a unique opportunity to change a wide community of practice. CRO has available access to an extensive network of non-oncology physicians and other medical professionals including geneticists as well as a broad network of community service providers. Based on its experience and expansion, CRO is confident it can secure over 200 accruals and credits per year in cancer treatment, prevention, and control. CRO is enthusiastic about the realignment of scope in research trials including expanded plans for cancer prevention and control. CRO fully supports new NCORP priorities to address cancer care delivery and disparities are consistent with ongoing efforts to improve access, service delivery, and outcomes at all CRO components.